Keynote B21 - Pembrolizumab in High-Risk Endometrial Cancer (Video Explainer) Last updated on Oct 27, 2024 Previous Keynote B-21: Pembrolizumab vs. Placebo in High-risk Endometrial Cancer Next The Living Room
